Align Technology, Inc. vs Global X Lithium & Battery Tech ETF — how do they compare? Align Technology, Inc. trades at $183.13 (market cap $12.86B), while Global X Lithium & Battery Tech ETF trades at $70.91. The key difference: Align Technology, Inc. is trading nearer its 52-week high, Global X Lithium & Battery Tech ETF nearer its low. Which is the better fit depends on your goals.
| ALGN | LIT | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $207.19 | $91.62 |
52-Week Low | $124.88 | $39.73 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
LIT trades at $72.32, down 0.69% today, with a bearish technical signal from moving averages but oversold RSI readings. Recent news highlights strong momentum in EV and battery tech sectors, with global EV sales rising and China targeting 30% NEV fleet by 2030. The ETF has doubled over the past year, driven by energy storage and semiconductor catalysts, though key financial ratios are currently unavailable.
Outlook remains cautiously optimistic given sector tailwinds, but risks include regulatory pressures, Chinese market access tensions, and reliance on lithium price stability. Analyst sentiment is mixed, with some highlighting rebound potential while technical indicators suggest near-term caution.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →LIT invests in the full lithium cycle, from mining and refining to battery production and EV manufacturing. It tracks the Solactive Global Lithium Index, with top holdings including Rio Tinto, Albemarle, and Tesla, as well as major battery makers like Samsung SDI.
Read more on LIT →